Phlebotomy Frequency and Quality of Life and Productivity in Patients with Polycythemia Vera: Results from the MPN Landmark Survey in the United States
Salman Fazal(Allegheny Health Network), Ruben A. Mesa(Atrium Health Wake Forest Baptist), Shreekant Parasuraman(Incyte (United States)), Maureen Thyne(Cornell University), John Mascarenhas(Tisch Hospital), Dilan Paranagama(Incyte (United States)), Ahmad Naim(Incyte (United States)), Sara Goldberger(Cancer Support Community), Carole B. Miller(Saint Agnes Hospital), James K. Mangan(UC San Diego Health System)
Cited by 5
Related Papers
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation
|Journal of Clinical Oncology|2001|682
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
|Journal of Clinical Oncology|2012|461
Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients
|Antimicrobial Agents and Chemotherapy|1993|344